The Global Glioma Diagnosis and Treatment Market report explores the Industry Opportunities, Drivers and Top Players in-depth. Global Glioma Diagnosis and Treatment market is expected to grow at a CAGR of approximately 10.1% during the forecast period, 2017–2023.
A glioma is a type of tumor that originates in the brain and is also known as a primary brain tumor. There are numerous types of gliomas which are entitled based on the origin of the cell type including oligodendrogliomas, astrocytoma, ependymomas, and glioblastoma. Nearly 33 percent of all brain tumors are gliomas. These originate in glial cells surrounding the neurons in the brain. According to the American Brain Tumor Association, more than 79,000 new cases of primary brain tumors were diagnosed in 2017 with 24.7% of those being gliomas.
Astrocytoma is the most common types of glioma diagnosed worldwide, as more than 30% of all the diagnosed cases with brain tumors are astrocytoma. These types of tumors are not curable as they spread easily through normal brain tissue. The American Brain Tumor Association has evaluated that around 7% of all the primary brain tumors represent astrocytoma.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/5877 .
Global Glioma Diagnosis and Treatment Market Players:
Thermo Fisher Scientific Inc. (U.S.), Emcure Pharmaceuticals Ltd. (India), Sigma-Aldrich Co. (U.S.), Pfizer Inc. (U.S.), Taj Pharmaceuticals Limited (India), Novartis International AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), GE Healthcare (U.S.), Siemens Healthineers (U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Merck & Co., Inc. (U.S.), F. Hoffmann-Le Roche AG (Switerland), Arbor Pharmaceuticals, LLC (U.S.), Sun Pharmaceutical Industries, Ltd. (India), Amneal Pharmaceuticals. LLC (U.S.), AstraZeneca (UK), Carestream Health (U.S.), Hitachi Medical Corporation (U.S.) and others.
Glioma Diagnosis and Treatment Market Segmentation:
The Glioma Diagnosis and Treatment Market is segmented on the basis of type, diagnosis, treatment, grade, location, and end-user.
On the basis of type, the global glioma diagnosis and treatment market is segmented into primary tumors and secondary tumors. Primary tumors are divided into ependymomas, astrocytoma, oligodendrogliomas, brainstem glioma, optic nerve glioma, mixed gliomas, and others.
The ependymomas segment is divided into subependymomas (grade i), myxopapillary ependymomas (grade i), ependymomas (grade ii), and anaplastic ependymomas (grade iii). The astrocytomas segment is divided into anaplastic astrocytomas, glioblastoma multiforme, and benign astrocytomas. The optic nerve glioma segment is divided into malignant optic nerve glioma and benign optic nerve glioma. The mixed gliomas are divided into oligoastrocytomas and others.
On the basis of diagnosis, the global glioma diagnosis and treatment market is classified into neurological exam, Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) scan, biopsy, molecular testing, Electroencephalography (EEG), and others.
On the basis of treatment, the global glioma diagnosis and treatment market is classified into surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. Furthermore, the surgery is further categorized into open surgery and minimally invasive surgery.
On the basis of grade, the global glioma diagnosis and treatment market is segmented into low-grade gliomas, high-grade gliomas, and recurrent high-grade glioma.
On the basis of location, the global glioma diagnosis and treatment market is segmented into supratentorial and infratentorial.
On the basis of end-user, the global glioma diagnosis and treatment market is classified into hospitals and clinics, diagnostic centers, medical research centers, and others.
Get Discount @ https://www.marketresearchfuture.com/check-discount/5877 .
Major TOC For Global Glioma Diagnosis and Treatment Market Research report forecast to 2023:
1 Report Prologue
2 Market Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 Assumptions & Limitations
2.4 Market Structure
3 Research Methodology
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4 Market Dynamics
4.1.1 Rise in demand for Glioma Diagnosis and Treatment will boost the growth globally (Impact weightage 40%)
LIST OF TABLE
Table 1 Glioma Diagnosis And Treatment Industry Synopsis, 2017–2023
Table 2 Glioma Diagnosis And Treatment Market Estimates And Forecast, 2017–2023, (USD Million)
Table 3 Glioma Diagnosis And Treatment Market, By Region, 2017–2023, (USD Million)
Table 4 Glioma Diagnosis And Treatment Market, By Type, 2017–2023, (USD Million)
Table 5 Glioma Diagnosis And Treatment Market, By Diagnosis, 2017–2023, (USD Million)
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/5877 .
LIST OF FIGURE
Figure 1 Research Process
Figure 2 Segmentation For Glioma Diagnosis And Treatment Market
Figure 3 Segmentation Market Dynamics For Glioma Diagnosis And Treatment Market
Figure 4 Global Glioma Diagnosis And Treatment Market Share, By Type 2016
Figure 5 Global Glioma Diagnosis And Treatment Market Share, By Diagnosis 2016
Figure 6 Global Glioma Diagnosis And Treatment Market Share, By Treatment, 2016
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312